Absci (ABSI) Net Equity Issued and Repurchased (2020 - 2026)

Absci (ABSI) posted Net Equity Issued and Repurchased of $8.0 million for Q1 2026, up 127.41% sequentially from $3.5 million in Q4 2025, and down 80.91% YoY from $41.7 million in Q1 2025.

Absci (ABSI) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

Absci has reported Net Equity Issued and Repurchased for 7 years, with the latest figure at $8.0 million in Q1 2026.

  • Quarterly Net Equity Issued and Repurchased fell 80.91% year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72.1 million (up 66.67% YoY) and the FY2025 annual result came in at $105.8 million, up 28.44% from the prior year.
  • Net Equity Issued and Repurchased improved to $8.0 million in Q1 2026 per ABSI's latest filing, from $3.5 million in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $80.8 million in Q1 2024 and troughed at -$2.2 million in Q4 2024.
  • A 5-year average of $12.3 million and a median of $304500.0 in 2023 frame the typical range for Net Equity Issued and Repurchased.
  • The sharpest annual moves came in 2023 and 2024: Net Equity Issued and Repurchased plunged 1198.48% in 2023, then surged 35195.63% in 2024.
  • Over 5 years, Net Equity Issued and Repurchased stood at $66000.0 in 2022, then slumped by 1198.48% to -$725000.0 in 2023, then plunged by 204.69% to -$2.2 million in 2024, then soared by 258.4% to $3.5 million in 2025, then surged by 127.41% to $8.0 million in 2026.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $8.0 million, $3.5 million, and $60.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Absci 1.58 Bn 1.37 Bn - 98.14 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 98.14 Mn
Jun 30, 2026 98.14 Mn
Mar 31, 2026 7.96 Mn
Mar 31, 2026 7.96 Mn
Dec 31, 2025 3.50 Mn
Dec 31, 2025 3.50 Mn
Sep 30, 2025 60.65 Mn
Sep 30, 2025 60.65 Mn
Mar 31, 2025 41.69 Mn
Mar 31, 2025 41.69 Mn
Dec 31, 2024 -2.21 Mn
Dec 31, 2024 -2.21 Mn
Sep 30, 2024 1.39 Mn
Sep 30, 2024 1.39 Mn
Jun 30, 2024 2.39 Mn
Jun 30, 2024 2.39 Mn
Mar 31, 2024 80.83 Mn
Mar 31, 2024 80.83 Mn
Dec 31, 2023 -725,000.00
Dec 31, 2023 -725,000.00